Cyclacel pharmaceuticals to present at the ladenburg thalmann 2022 healthcare conference

Berkeley heights, n.j., sept. 21, 2022 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that management will participate in ladenburg thalmann's 2022 healthcare conference on september 29, 2022 at the sofitel new york.
CYCC Ratings Summary
CYCC Quant Ranking